Paper Details

  1. Home
  2. Paper Details

Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion.

Author: BeckmannX J, BrundageB H, CaoT, GeorgiouD, GinztonL E, MandayamS, OudizR J, RomanoM A, ShapiroS M

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Patients receiving continuous infusion of epoprostenol for treatment of primary pulmonary hypertension experience a decrease in pulmonary artery pressure and demonstrate improved long-term survival compared with historical control subjects.
Paper Details　
Original Abstract of the Article :
OBJECTIVES: This study sought to determine the long-term effects of continuous infusion of epoprostenol (epo) therapy on survival and pulmonary artery pressure in patients with primary pulmonary hypertension (PPH). BACKGROUND: PPH is a progressive disease for which there are few effective therapies...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0735-1097(97)00187-3

データ提供：米国国立医学図書館（NLM）

Epoprostenol: A Lifesaver for Pulmonary Hypertension

This study focuses on the use of continuous intravenous epoprostenol (epo) infusion for treating primary pulmonary hypertension (PPH), a serious condition that affects the heart and lungs. The researchers investigated the long-term effects of epo therapy on survival and pulmonary artery pressure in patients with PPH. They found that epo therapy significantly reduced pulmonary artery pressure and improved survival rates compared to historical control groups.

Epoprostenol: A Breakthrough Treatment

This study provides compelling evidence for the effectiveness of epoprostenol in treating PPH. The researchers found that epo therapy significantly reduced pulmonary artery pressure and improved survival rates compared to historical control groups. This study underscores the importance of early diagnosis and treatment for PPH to improve patient outcomes.

Understanding Pulmonary Hypertension

This study highlights the importance of understanding and effectively treating PPH, a serious condition that can significantly impact quality of life. It underscores the potential of epoprostenol to improve outcomes for patients with this condition.

Dr.Camel's Conclusion

This study focuses on the use of continuous intravenous epoprostenol (epo) infusion for treating primary pulmonary hypertension (PPH), a serious condition that affects the heart and lungs. The researchers investigated the long-term effects of epo therapy on survival and pulmonary artery pressure in patients with PPH. They found that epo therapy significantly reduced pulmonary artery pressure and improved survival rates compared to historical control groups. This study provides compelling evidence for the effectiveness of epoprostenol in treating PPH. The researchers found that epo therapy significantly reduced pulmonary artery pressure and improved survival rates compared to historical control groups. This study underscores the importance of early diagnosis and treatment for PPH to improve patient outcomes.

Date :
  1. Date Completed 1997-08-25
  2. Date Revised 2019-07-08
Further Info :

Pubmed ID

9247503

DOI: Digital Object Identifier

10.1016/s0735-1097(97)00187-3

Related Literature

Article Analysis
・Effects of epoprostenol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.